BeStock  
Stocks › ARQT

Arcutis Biotherapeutics ARQT

US equityMarket cap rank #2441
$25.15 −$0.01 (-0.04%)
Pre-market · Oct 6, 7:40 am ET · After hours $25.25 +0.40%
Open$25.09
Prev close$25.16
Day range$24.69 – $25.39
Volume2.31M
Market cap$3.16B
P/E (TTM)114.3
Dividend yield–

Earnings

Average move on report day±9.4%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+27.0%
Worst reaction-18.8%

Stock move on the day after each report

+9.9%2023/Q3+9.7%2023/Q4+13.7%2024/Q1-11.3%2024/Q2+7.7%2024/Q3+8.4%2024/Q4-4.3%2025/Q1-8.1%2025/Q2+27.0%2025/Q3+5.8%2025/Q4-14.5%2026/Q1-2.5%2026/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q25 Aug 2026After Market±12.5%-2.47%Within range
2026/Q16 May 2026After Market±9.7%-14.52%Bigger than priced
2025/Q425 Feb 2026After Market±13.2%+5.78%Within range
2025/Q328 Oct 2025Pre Market±15.8%+27.04%Bigger than priced
2025/Q26 Aug 2025After Market±14.2%-8.07%Within range
2025/Q16 May 2025After Market±18.9%-4.33%Within range
2024/Q425 Feb 2025After Market±25.5%+8.36%Within range
2024/Q36 Nov 2024After Market±20.1%+7.66%Within range
2024/Q214 Aug 2024After Market±17.7%-11.27%Within range
2024/Q114 May 2024After Market±33.3%+13.65%Within range
2023/Q427 Feb 2024Pre Market±31.1%+9.70%Within range
2023/Q33 Nov 2023Pre Market±27.9%+9.91%Within range
2023/Q28 Aug 2023After Market±20.3%-4.48%Within range
2023/Q19 May 2023After Market±14.4%-18.83%Bigger than priced
2022/Q428 Feb 2023After Market±18.4%+3.15%Within range
2022/Q38 Nov 2022After Market–-0.43%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q2

By business line

  • ZORYVE foam$67.38M 51.9%
  • ZORYVE cream 0.3%$35.33M 27.2%
  • ZORYVE cream 0.15%$24.23M 18.7%
  • ZORYVE cream 0.05%$2.93M 2.3%

Fundamentals

Full statements →

Latest reported quarter: Q2, ended Jun 2026

Revenue$129.86M+59.3% YoY
Operating profit$16.43M+212.4% YoY
Net profit$15.01M+194.5% YoY
Diluted EPS$0.11+184.6% YoY

Revenue, last 8 quarters

$44.8MSep '24$71.4MDec '24$65.8MMar '25$81.5MJun '25$99.2MSep '25$129.5MDec '25$105.4MMar '26$129.9MJun '26

Net profit, last 8 quarters

$-41.5MSep '24$-10.8MDec '24$-25.1MMar '25$-15.9MJun '25$7.4MSep '25$17.4MDec '25$-11.3MMar '26$15.0MJun '26

Profitability & balance sheet

Gross margin90.2%
Operating margin-3.3%
Net margin-4.3%
Return on equity-9.3%
Return on assets-4.1%
Return on invested capital-4.8%
Current ratio3.17
Liabilities / assets54.8%
Cash & investments$238.55M
Total debt$114.14M
Net cash (debt)$124.42M

Discussion

No comments yet — be the first to weigh in on ARQT.

Leave a comment

Scroll to Top